Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Glenn

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Novel therapies for hepatitis C virus based on lessons from virologyJeffrey S Glenn
Gastroenterology & Hepatology|April 25, 2022
Hepatitis Delta Virus Testing and ResearchJeffrey S Glenn
Clinics in Liver Disease|July 19, 2005
Molecular virology of the hepatitis C virus: implication for novel therapiesJeffrey S Glenn
Hepatology (Baltimore, Md.)|June 9, 2004
Overdependence on the host-an Achilles' heel of HCV?Jeffrey S Glenn
Infectious Disease Clinics of North America|March 11, 2006
Molecular virology of the hepatitis C virus: implication for novel therapiesJeffrey S Glenn
Gastroenterology & Hepatology|March 2, 2018
Emerging Therapeutic Targets for Hepatitis Delta Virus InfectionJeffrey S Glenn
Viruses|February 26, 2022
Combination of Novel Therapies for HDVMenashe Elazar, Jeffrey S Glenn
Gastroenterology|July 1, 2014
HCV NS5A inhibitors: the devil is in the detailsMenashe Elazar, Jeffrey S Glenn
Current Opinion in Virology|May 6, 2017
Emerging concepts for the treatment of hepatitis deltaMenashe Elazar, Jeffrey S Glenn
Health Security|December 28, 2022
Programmable Antivirals and Just-in-Time Vaccines: Biosecurity Implications of Viral RNA Secondary Structure TargetingJaspreet Pannu, Jeffrey S Glenn
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Novel therapies for hepatitis C virus based on lessons from virologyJeffrey S Glenn
Gastroenterology & Hepatology|April 25, 2022
Hepatitis Delta Virus Testing and ResearchJeffrey S Glenn
Clinics in Liver Disease|July 19, 2005
Molecular virology of the hepatitis C virus: implication for novel therapiesJeffrey S Glenn
Hepatology (Baltimore, Md.)|June 9, 2004
Overdependence on the host-an Achilles' heel of HCV?Jeffrey S Glenn
Infectious Disease Clinics of North America|March 11, 2006
Molecular virology of the hepatitis C virus: implication for novel therapiesJeffrey S Glenn
Gastroenterology & Hepatology|March 2, 2018
Emerging Therapeutic Targets for Hepatitis Delta Virus InfectionJeffrey S Glenn
Viruses|February 26, 2022
Combination of Novel Therapies for HDVMenashe Elazar, Jeffrey S Glenn
Gastroenterology|July 1, 2014
HCV NS5A inhibitors: the devil is in the detailsMenashe Elazar, Jeffrey S Glenn
Current Opinion in Virology|May 6, 2017
Emerging concepts for the treatment of hepatitis deltaMenashe Elazar, Jeffrey S Glenn
Health Security|December 28, 2022
Programmable Antivirals and Just-in-Time Vaccines: Biosecurity Implications of Viral RNA Secondary Structure TargetingJaspreet Pannu, Jeffrey S Glenn
Pageof 13